Opendata, web and dolomites

SQUALAC

Preclinical development of squalenic acid and gemcitabine squalene nanomedicine

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SQUALAC project word cloud

Explore the words cloud of the SQUALAC project. It provides you a very rough idea of what is the project "SQUALAC" about.

construct    property    gemcitabine    linkage    squalene    squalenic    grant    tumor    efficient    chemical    sqco2h    itself    remarkably    discovered    bioconjugates    self    assemble    treatment    goals    environmental    therapy    data    confers    platform    acceptable    excessive    economical    anticancer    chemistry    cosmetics    clinic    sq    triggered    drugs    tumors    lock    deserve    preparation    display    never    synthesis    remarkable    employed    shown    course    molecular    parent    clinical    hunting    conformation    excipient    moiety    nanomedicines    cro3    impressive    shark    overcome    disease    template    acid    innovation    perform    translation    reaction    incidentally    cancer    pancreatic    gem    ing    loading    nanomedicine    green    total    folded    ternanomed    spacer    drug    first    regulatory    candidate    release    poor    natural    compound    devastating    raquo    bioconjugate    van    lipid    resistance    laquo    nanoparticles    erc    tamelen    toxic    experimental    yield    pharmaceutical    squalenoylation   

Project "SQUALAC" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITE PARIS-SUD 

Organization address
address: RUE GEORGES CLEMENCEAU 15
city: ORSAY CEDEX
postcode: 91405
website: www.u-psud.fr

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 150˙000 €
 EC max contribution 150˙000 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2014-PoC
 Funding Scheme ERC-POC
 Starting year 2015
 Duration (year-month-day) from 2015-03-01   to  2016-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITE PARIS-SUD FR (ORSAY CEDEX) coordinator 150˙000.00

Map

 Project objective

'In the course of the ERC Advanced Grant TERNANOMED, we have discovered that the linkage of squalene (a natural lipid) to many drugs, confers to the resulting bioconjugates the remarkable property to self-assemble as nanoparticles, due to the folded molecular conformation of squalene. This approach is unique and has never been used before. The so called 'squalenoylation' technology may be considered as a generic platform to construct nanomedicines with high drug loading and targeted drug release triggered by the spacer between the drug and the squalene moiety. Remarkably, it was shown that these nanomedicines were more efficient and less toxic than the parent drugs. The gemcitabine-squalene (Gem-SQ) nanomedicine, our first candidate for further pharmaceutical developments, was shown not only to display an impressive anticancer activity in experimental tumors but also to overcome drug resistance, thus addressing a major challenge in tumor therapy. These pre-clinical data deserve further development towards translation into the clinic for the treatment of the pancreatic cancer, a devastating disease. However, the squalenic acid (SQCO2H), the chemical template essential for the synthesis of the Gem-SQ bioconjugate, is currently obtained through the Van Tamelen reaction which cannot be employed for the preparation of a clinical sample of Gem-SQ, because of the use of CrO3 (a toxic compound) and the poor yield of the reaction. Therefore, the synthesis of SQCO2H represents a lock for further clinical development of our Gem-SQ nanomedicine. The goals of the present proposal are : (i) to perform the total synthesis of SQCO2H through a new « green » chemistry way (which represents in itself a real innovation) allowing (ii) further regulatory acceptable preparation of Gem-SQ nanoparticles. Incidentally, the total synthesis of SQCO2H will avoid environmental concern due to excessive shark hunting and represents by itself some economical value as excipient for the cosmetics.'

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SQUALAC" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SQUALAC" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

evolSingleCellGRN (2019)

Constraint, Adaptation, and Heterogeneity: Genomic and single-cell approaches to understanding the evolution of developmental gene regulatory networks

Read More  

IMMUNOTHROMBOSIS (2019)

Cross-talk between platelets and immunity - implications for host homeostasis and defense

Read More  

RODRESET (2019)

Development of novel optogenetic approaches for improving vision in macular degeneration

Read More